QA: Immune Design CORP in us_pharma/2015

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001437786_2016_Immune_Design_CORP.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}
info NetIncome node detected by revenue/expenses heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'OperatingIncomeLoss'}

Graph

Absolute values for 0001437786, Immune Design CORP

  xvar xval
0 AssetsCurrent 115,560,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 585,000
3 remainder_Assets 0
4 LiabilitiesCurrent 7,111,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 15,134,000
9 ResearchAndDevelopmentExpense 33,087,000
10 remainder_Expenses 774,000
11 remainder_Revenues 9,510,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 116,145,000
1 Liabilities 7,111,000
2 Expenses 48,995,000
3 Revenues 9,510,000
4 StockholdersEquity 109,034,000
5 NetIncome -39,485,000
6 ComprehensiveNetIncome -39,485,000
7 BaseVar 90,880,500
8 EconomicCapitalRatiobeforeLimitedLiability 3.22
9 EconomicCapitalRatio 3.83

Edgar->Model Mapping

Feature Distribution

Change over Time